Skip to main content
SpringerLink
Log in
Book cover

Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS pp 855–873Cite as

Neurological and Psychiatric Disorders in Renal Diseases

  • Chapter

  • 306 Accesses

Abstract

Neurological abnormalities specifically related to uremia constantly occur in patients with end-stage renal disease (ESRD), although they only become clinically well defined in severe acute renal failure (ARF) or late in the course of chronic renal failure (CRF) and sometimes in connection with metabolic acidosis and/or electrolyte disturbances secondary to renal disease (1–5).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Tyler HR: Neurological aspects of uremia. An overview. Kidney Int 1 (Suppl 2): S188 - S193, 1975.

    Google Scholar 

  2. Raskin NH, Fishman RA: Neurologic disorders in renal failure. N Engl J Med 294: 143–148, 1976.

    Article  PubMed  CAS  Google Scholar 

  3. Fräser CL, Arieff AL: Nervous system complications in uremia. Ann Intern Med 109: 143–153, 1988.

    Article  PubMed  Google Scholar 

  4. Jennekens FGI, Jennekens-Schinkel A: Neurological aspects of dialysis patients. In: JF Maher, ed, Replacement of Renal Function by Dialysis. Kluwer Academic Publishers, Boston, pp 972–986, 1989.

    Chapter  Google Scholar 

  5. Cappelli P, Di Paolo B, Albertazzi A: Neurological complications of the uremic syndrome. In: S Giovannetti, ed, Nutritional Treatment of Chronic Renal Failure. Kluwer Academic Publishers, Boston, pp 95–99, 1989.

    Chapter  Google Scholar 

  6. Bolton CF, Young GB: Neurological Complications of Renal Disease. Butterworth Publishers, Boston, 1990.

    Google Scholar 

  7. lohnson M, Davison AM: The nervous system and the kidney. In: S Cameron, AM Davison, J-P Grunfeld, D Kerr, E Ritz, eds, Oxford Textbook of Clinical Nephrology. Oxford University Press, New York, pp 2323–2333, 1992.

    Google Scholar 

  8. Locke SJ, Merril JP, Tyler HR: Neurological complications of acute uremia. Arch Intern Med 108: 75–86, 1961.

    Article  Google Scholar 

  9. Ginn HE: Neurobehavioral dysfunction in uremia. Kidney Int 7 (Suppl 2): S217 - S225, 1975.

    Google Scholar 

  10. Albertazzi A, Di Paolo B, Cappelli P, Spisni C, Del Rosso G: Evoked potentials in uremia. Contrib Nephrol 45: 60–68, 1985.

    PubMed  CAS  Google Scholar 

  11. Di Paolo B, Di Marco T, Cappelli P, Spisni C, Del Rosso G, Palmieri PF, Evangelista M, Albertazzi A: Electrophysiological aspects of nervous conduction in uremia. Clin Nephrol 29: 253–260, 1988.

    PubMed  Google Scholar 

  12. Teschan PE, Ginn HE, Bourne JR, Ward JW, Amel B, Nummally IC, Musso M, Vaughn WK: Quantitative indices of clinical uremia. Kidney Int 15: 676–697, 1979.

    Article  PubMed  CAS  Google Scholar 

  13. Hagstam KE: EEG frequency content related to chemical blood parameters in chronic uremia. Scand J Urol Nephrol 1 (Suppl l):l-9, 1971.

    Google Scholar 

  14. Albertazzi A, Di Paolo B, Del Rosso G, Gambi D, Rossini PM: Neurophysiological abnormalities in uraemic encephalopathy. Proc Eur Dial Transplant Assoc Eur Ren Assoc 18: 652–657, 1981.

    CAS  Google Scholar 

  15. Rossini PM, Pirchio M, Treviso M, Gambi D, Di Paolo B, Albertazzi A: Checkerboard reversal pattern and flash VEPs in dialysed and nondialysed subjects. Electroencephalogr Clin Neurophysiol 52: 435–444, 1981.

    Article  PubMed  CAS  Google Scholar 

  16. Weber B, Hacke W, Stiller S, Mann H: Evaluation of uremic neuropathy by visual (VEP) and brainstem auditory (BAEP) evoked potentials. Trans Am Soc Artif Intern Organs 31: 586–589, 1985.

    PubMed  CAS  Google Scholar 

  17. Brown 1J, Sufit RL, Sollinger HW: Visual evoked potential changes following renal transplantation. Electroencephalogr Clin Neurophysiol 66: 101–107, 1987.

    Article  PubMed  CAS  Google Scholar 

  18. Rossini PM, Di Stefano E, Febbo A, Di Paolo B, Basciani M: Brainstem auditors evoked responses (BAERs) in patients with chronic renal failure. Electroencephalogr Clin Neurophysiol 57: 507–514, 1984.

    Article  PubMed  CAS  Google Scholar 

  19. Komsuoglu SS, Mehta R, lones LA, Harding GFA: Brainstem auditory evoked potentials in chronic renal failure and maintenance hemodialysis. Neurology 35:419-423,1985.

    Google Scholar 

  20. Rossini PM, Treviso M, Di Stefano E, Di Paolo B: Nervous impulse propagation along peripheral and central fibres in patients with chronic renal failure. Electroencephalogr Clin Neurophysiol 56: 293–303, 1983.

    Article  PubMed  CAS  Google Scholar 

  21. Albertazzi A, Di Paolo B, Amoroso L: Central and peripheral nervous system in dialysis patients: CAPD vs HD. In: G La Greca, S Chiaramonte, eds, Peritoneal Dialysis. Wichtig Editore, Milano, pp 281–286, 1988.

    Google Scholar 

  22. Olsen S: The brain in uremia. Acta Psychiatr Neurol Scand 36 (Suppl 156): 3–129, 1961.

    Google Scholar 

  23. Arieff AI: Neurological manifestations of uremia. In: BM Brenner, FC Rector, eds, The Kidney. WB Saunders, Philadelphia, pp 1731–1756, 1986.

    Google Scholar 

  24. Akmal M, Goldstein DA, Multani S, Massry S, Massry SG: The role of uremia, brain Ca and PTH on change in EEG in chronic renal failure. Am J Physiol 246: F575, 1984.

    PubMed  CAS  Google Scholar 

  25. Massry SG: Current status of the role of parathyroid hormone in uremic toxicity. Contrib Nephrol 49: 1–11, 1985.

    PubMed  CAS  Google Scholar 

  26. Mitch WE, Walser M: Nutritional therapy of the uremic patient. In: BM Brenner, FC Rector, eds, The Kidney, 4th ed. WB Saunders, Philadelphia, pp 2186–2222, 1991.

    Google Scholar 

  27. Bergstrom J, Lindblom U, Noree L-O: Preservation of peripheral nerve function in severe uremia during treatment with low protein high calorie diet and surplus of essential amino acids. Acta Neurol Scand 51: 99–109, 1975.

    Article  PubMed  CAS  Google Scholar 

  28. Cappelli P, Di Paolo B, Evangelista M, Di Marco T, Albertazzi A: Low-protein diet supplemented with essential amino acids and keto analogues. Effects on uremic polyneuropathy and encephalopathy. Contrib Nephrol 53: 58–63, 1986.

    PubMed  CAS  Google Scholar 

  29. Giovannetti S: Dietary treatment of chronic renal failure: Why is it not used more frequently? Nephron 40: 1–12, 1985.

    Article  PubMed  CAS  Google Scholar 

  30. Cappelli P, Di Paolo B, Albertazzi A: Effects of nutritional treatment on the course of uremic neuropathy. In: S Giovannetti, ed, Nutritional Treatment of Chronic Renal Failure. Kluwer Academic Publishers, Boston, pp 255–257, 1989.

    Chapter  Google Scholar 

  31. Rozeman CAM, Jonkman El, Poortvliet DC1, Emmen HH, de Weerd AW, van der Maas APC, Tjandra YI, Beermann EM: Encephalopathy in patients on continuous ambulatory peritoneal dialysis and patients on chronic haemodialysis. Nephrol Dial Transplant 7: 1213–1218, 1992.

    PubMed  CAS  Google Scholar 

  32. Nissenson AR: Epoetin and cognitive function. Am J Kidney Dis 20 (Suppl l): 21–24, 1992.

    PubMed  CAS  Google Scholar 

  33. Sagales T, Gimeno V, Planella MJ, Raguer N, Bartolome J: Effects of rHuEPO on Q-EEG and event-related potentials in chronic renal failure. Kidney Int 44: 1109–1115, 1993.

    Article  PubMed  CAS  Google Scholar 

  34. Levinsky NG: Fluids and electrolytes—acidosis and alkalosis. In: ID Wilson, E Braunwald, KJ Isselbacher, RG Petersdorf, JB Martin, AS Fauci, RK Root, eds, Harrison’s Principles of Internal Medicine, 12th ed. McGraw-Hill, New York, pp 278–295, 1991.

    Google Scholar 

  35. Andreoli TE: Disorders of fluid volume, electrolyte, and acid-base balance. In: IB Wyngaarden, LH Smith, 1C Bennet, eds, Cecil Textbook of Medicine, 19th ed. WB Saunders, Philadelphia, pp 499–527, 1992.

    Google Scholar 

  36. Nielsen VK: The peripheral nerve function in chronic renal failure. I. Clinical signs and symptoms. Acta Med Scand 190: 105–111, 1971.

    Article  PubMed  CAS  Google Scholar 

  37. Di Paolo B, Cappelli P, Spisni C, Albertazzi A, Rossini PM, Marchionno L, Gambi D: New electrophysiological assessments for the early diagnosis of encephalopathy and peripheral neuropathy in uremia. Int J Tissue React 4: 301–307, 1982.

    PubMed  Google Scholar 

  38. Nielsen VK: The peripheral nerve function in chronic renal failure. VI. Relationship between sensory and motor function and kidney function, azotemia, age, sex and clinical neuropathy. Acta Med Scand 194: 455–162, 1973.

    Article  PubMed  CAS  Google Scholar 

  39. Ahonen RE: Peripheral neuropathy in uremic patients and in renal transplant recipients. Acta Neuropathol 54: 43–53, 1981.

    Article  PubMed  CAS  Google Scholar 

  40. Spencer PS, Schaumberg HH: Central-peripheral distal axonopathy. The pathology of “dying-back” polyneuropathies. Proc Neuropathol 3: 253–255, 1977.

    Google Scholar 

  41. Savazzi GM, Cambi V, Migone L, Marbini A, Govoni E, Bragaglia MM, Juvarra G, D’Aglio PP: The influence of uraemic neuropathy on muscle EMG, histoenzymatic and ultrastructural correlation. Proc Eur Dial Transplant Assoc Eur Ren Assoc 17: 312–317, 1980.

    CAS  Google Scholar 

  42. Tegner R, Lindholm B: Vibratory perception threshold compared with nerve conduction velocity in the evaluation of uremic neuropathy. Acta Neurol Scand 71: 290–297, 1985.

    PubMed  Google Scholar 

  43. Dyck PJ, Johnson WJ, Lambert EH, O’Brien PC: Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc 46: 400–531, 1971.

    PubMed  CAS  Google Scholar 

  44. Rosales RL: Normal sural nerve morphometry in acute uremia. J Neurol Neurosurg Psychiatry 50: 942–943, 1987.

    Article  PubMed  CAS  Google Scholar 

  45. Albertazzi A, Cappelli P, Bonomini M, Del Rosso G, Di Paolo B, Evangelista M, Palmieri PF: Role of essential amino acids and ketoanalogues in antagonizing uremic catabolism. Contrib Nephrol 98: 167–173, 1992.

    PubMed  CAS  Google Scholar 

  46. Violante F, Lorenzi S, Fusello M: Uremic neuropathy: clinical and neurophysiological investigation of dialysis patients using different chemical membranes. Eur Neurol 24: 398–104, 1985.

    Article  PubMed  CAS  Google Scholar 

  47. Tegner R, Lindholm B: Uremic polyneuropathy: different effects of hemodialysis and continuous ambulatory peritoneal dialysis. Acta Med Scand 218: 409–416, 1985.

    Article  PubMed  CAS  Google Scholar 

  48. Yokota S, Takagi H, Kumano K, Sakai T: Peripheral nerve function in patients on CAPD as compared to hemodialysis. In: K Ota, ed, Current Concepts in Peritoneal Dialysis, Elsevier Science Publishers BV, Amsterdam, pp 587–592, 1992.

    Google Scholar 

  49. De Fijter CWH, Oe PL, Strijers RLM, Ven Der Meulen J, Ter Wu PM, Donker AJM: The course of uremia-associated peripheral neuropathy: chronic peritoneal dialysis (CPD) versus chronic hemodialysis (CHD). In: K Ota, ed, Current Concepts in Peritoneal Dialysis, Elsevier Science Publishers BV, Amsterdam, pp 593–597, 1992.

    Google Scholar 

  50. Nielsen VK: The peripheral nerve function in chronic renal failure. VII. Recovery after renal transplantation. Acta Med Scand 195: 171–180, 1974.

    Article  PubMed  CAS  Google Scholar 

  51. Bolton CF: Electrophysiologic changes in uremic neuropathy after successful renal transplantation. Neurology 26: 152–161, 1976.

    Article  PubMed  CAS  Google Scholar 

  52. Albertazzi A, Di Paolo B, Cappelli P, Evangelista M, Di Marco T, Varanese L: Uremic polyneuropathy: electrophysiologic findings after renal transplantation. Transplant Proc 17: 121, 1985.

    Google Scholar 

  53. Brecht HM, Ernst W, Koch KM: Plasma noradrenaline levels in regular hemodialysis patients. Proc EDTA 12: 281–289, 1975.

    Google Scholar 

  54. Campese VM, Romoff MS, Levitan D, Lane K, Massry SG: Mechanisms of autonomic nervous dysfunction in uremia. Kidney Int 20: 246–253, 1981.

    Article  PubMed  CAS  Google Scholar 

  55. Campese VM, Massry SG: Autonomic nervous system. In: SG Massry, RJ Glassock, eds, Textbook of Nephrology. Williams & Wilkins, Baltimore, pp 1162–1165, 1989.

    Google Scholar 

  56. Zucchelli P, Sturani A, Zuccala A, Santoro A, Degli Esposti E, Chiarini C: Dysfunction of the autonomic nervous system in patients with end-stage renal failure. Contrib Nephrol 45: 69–81, 1985.

    PubMed  CAS  Google Scholar 

  57. Wilson JA, Yalya TM, Giles GR, Davison AM: The effect of haemodialysis and transplantation on autonomic neuropathy. Proc EDTA 16: 261–265, 1979.

    CAS  Google Scholar 

  58. Mäher J, Schreiner G: Hazards and complications of dialysis. N Engl J Med 273: 370–377, 1965.

    Article  PubMed  Google Scholar 

  59. Basil EC, Miller JDR, Koles Z, Grace M, Ulan RA: The effects of dialysis on brain water and EEG in stable chronic uremia. Am J Kidney Dis 9: 462–469, 1987.

    Google Scholar 

  60. Arieff AI: Dialysis disequilibrium syndrome. In: SG Massry, RJ Glassock, eds, Textbook of Nephrology. Williams & Wilkins, Baltimore, pp 1168–1170, 1989.

    Google Scholar 

  61. Arieff AI, Massry SG, Barrientos A, Kleeman CR: Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int 4: 177–187, 1973.

    Article  PubMed  CAS  Google Scholar 

  62. Arieff AI, Lazarowitz VC, Guisado R: Experimental dialysis disequilibrium syndrome: prevention with glycerol. Kidney Int 14: 270–278, 1978.

    Article  PubMed  CAS  Google Scholar 

  63. Posner JB, Plum F: Spinal fluid pH and neurologic symptoms in systemic acidosis. N Engl J Med 277: 605, 1977.

    Article  Google Scholar 

  64. Port FK, Johnson WJ, Klass DW: Prevention of dialysis dysequilibrium syndrome by the use of high sodium concentration in the dialysate. Kidney Int 3: 327–333, 1973.

    Article  PubMed  CAS  Google Scholar 

  65. Kennedy AC, Linton AL, Luke RG, Renfrew S: Electro-encephalographic changes during hemodialysis. Lancet i:408-111, 1963.

    Google Scholar 

  66. Rosa AA, Shideman J, McHugh R, Duncan D, Kjellstrand CM: The importance of osmolality fall and ultrafiltration rate on hemodialysis side effects: influence of intravenous manni-tol. Nephron 27: 134–141, 1981.

    Article  PubMed  CAS  Google Scholar 

  67. Raju SF, White AR, Barness TT, Smith PP, Kirchner KA: Improvement in dysequilibrium symptoms during dialysis with low glucose dialysate. Clin Nephrol 18: 126–129, 1982.

    PubMed  CAS  Google Scholar 

  68. Pagel MD, Ahmad S, Vizzo JE, Scribner BH: Acetate and bicarbonate fluctuations and acetate intolerance during dialysis. Kidney Int 21: 513–518, 1982.

    Article  PubMed  CAS  Google Scholar 

  69. Jack R, Rabin PL, McKinney TW: Dialysis encephalopathy: a review. Int J Psychiatry Med 13:309–326, 1983/1984.

    Google Scholar 

  70. Smith DB, Lewis JA, Burks JS, Alfrey AC: Dialysis encephalopathy in peritoneal dialysis. IAMA 244: 365–366, 1980.

    CAS  Google Scholar 

  71. Dewberry FL, McKinney TD, Stone WJ: The dialysis dementia syndrome: report of fourteen cases and review of the literature. Trans Am Soc Artif Intern Organs 3: 102–108, 1980.

    Google Scholar 

  72. Andreoli SP, Beegstein JM, Sherrard DJ: Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. N Engl J Med 310: 1079–1084, 1984.

    Article  PubMed  CAS  Google Scholar 

  73. Alfrey AC, LeGendre GR, Kaehney WD: The dialysis encephalopathy syndrome: possible aluminum intoxication. N Engl I Med 294: 184–188, 1976.

    Article  CAS  Google Scholar 

  74. Chokroverty S, Bruetman BE, Berger V, Reyes MG: Progressive dialytic encephalopathy. I Neurol Neurosurg Psychiatry 39: 411–419, 1976.

    Article  CAS  Google Scholar 

  75. Dunea G, Mahurkar SD, Mamdami B, Smith EC: Role of aluminum in dialysis dementia. Ann Intern Med 88: 502–504, 1978.

    Article  PubMed  CAS  Google Scholar 

  76. Davison AM, Oli H, Walker GS, Lewins AM: Water supply, aluminum concentration, dialysis dementia and effect of reverse-osmosis water treatment. Lancet ii: 785–786, 1982.

    Google Scholar 

  77. Mahoney CA, Arieff AI: Uremic encephalopathies: clinical, biochemical, and experimental features. Am J Kidney Dis 2: 324–336, 1982.

    PubMed  CAS  Google Scholar 

  78. Bommer J: Medical complications of the long-term dialysis patients. In: S Cameron, AM Davison, JP Grunfeld, D Kerr, E Ritz, eds, Oxford Textbook of Clinical Nephrology. Oxford University Press, New York, pp 1436–1458, 1992.

    Google Scholar 

  79. Kirschbaum BB, Schoolwarth AC: Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids. Am J Med Sci 297: 9, 1989.

    Article  PubMed  CAS  Google Scholar 

  80. Vasilakakis DM, D’Haese PC, Lamberts LV, Lemoniatou E, Digenis PN, De Broe ME: Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis. Kidney Int 41: 1400–1407, 1992.

    Article  PubMed  CAS  Google Scholar 

  81. Ackrill P, Ralston Al, Day JP, Hodge KC: Successful removal of aluminum from a patient with dialysis encephalopathy. Lancet ii: 692–693, 1980.

    Google Scholar 

  82. Boealaert JR, de Locht M: Side-effects of desferrioxamine in dialysis patients. Nephrol Dial Transplant Suppl 1: 43–46, 1993.

    Article  Google Scholar 

  83. Consensus Conference: Diagnosis and treatment of aluminum overload in end-stage renal failure patients. Nephrol Dial Transplant Suppl 1: 1–4, 1993.

    Google Scholar 

  84. Verpooten GA, D’Haese PC, Boelaert 1R, Becaus I, Lamberts LV, De Broe ME: Pharmakokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients. Nephrol Dial Transplant 7: 931–938, 1992.

    PubMed  CAS  Google Scholar 

  85. Davison AM, Giler GR: The effect of transplantation on dialysis dementia. Proc EDTA 16:407-112,1979.

    Google Scholar 

  86. Ball 1H, Butkus DE, Madison DS: Effect of subtotal parathyroidectomy on dialysis dementia. Nephron 18: 151, 1977.

    Article  PubMed  CAS  Google Scholar 

  87. De Gencarelli NC, Cournot-Witmer G, Zingraff J, Drueke T: The role of parathyroid function and parathyroidectomy in the outcome of aluminum-related dialysis encephalopathy. Nephrol Dial Transplant 1: 192–198, 1986.

    Google Scholar 

  88. Lewins AM: Aluminum intoxication. Proc EDTNA 10: 219 220, 1982.

    Google Scholar 

  89. Pagani C, Zoerle C, Guaita MC, Bazzi C, Sorgato G, Torti G: Carpal tunnel syndrome in long-term dialyzed patients. Contrib Nephrol 45: 82–96, 1985.

    PubMed  CAS  Google Scholar 

  90. Maiorca R, Cancarini GC, Camerini C, Brunori G, Manili L, Movilli E, Feller P, Mombelloni S: Is CAPD competitive with hemodialysis for long term treatment of uraemic patients? Nephrol Dial Transplant 4: 244–253, 1989.

    PubMed  CAS  Google Scholar 

  91. Halter SK, De Lisa 1A, Stolov W: Carpal tunnel syndrome in chronic renal dialysis patients. Arch Phys Med Rehabil 62: 197–201, 1981.

    PubMed  CAS  Google Scholar 

  92. Ritz E, Bommer 1: Beta-2 microglobulin derived amyloid problems and perspectives. Blood Purif 6: 61–68, 1988.

    Article  PubMed  CAS  Google Scholar 

  93. Chow JC: Endoscopic release of the carpal ligament: a new technique for carpal tunnel syndrome. Arthroscopy 5: 19–24, 1989.

    Article  PubMed  CAS  Google Scholar 

  94. Bechar M, Lakke IP, Hem GK, van der Becks 1W, Penning L: Subdural hematoma during long-term hemodialysis. Arch Neurol 26: 513–518, 1972.

    Article  PubMed  CAS  Google Scholar 

  95. McLachlan RS, Bolton CF, Coates RK, Barnett HIM: Gait disturbance in chronic subdural hematoma. Can Med Assoc J 125: 865–868, 1981.

    PubMed  CAS  Google Scholar 

  96. Tietjen DP, Moore 1 Jr, Gouge IF: Hemodialysis-associated acute subdural hematoma: interim management with peritoneal dialysis. Am J Nephrol 7: 478–485, 1987.

    Article  PubMed  CAS  Google Scholar 

  97. Tolkoff-Rubin NE, Nardini 1, Fang LST, Rubin RH: Successful hemodialysis of patients at high risk of hemorrhage using the Eval dialyzer. Dial Transplant 15: 125, 1986.

    Google Scholar 

  98. Rotter W, Roettger P: Comparative pathologic-anatomic study of cases of chronic global renal insufficiency with and without hemodialysis. Clin Nephrol 1: 257, 1974.

    Google Scholar 

  99. Lopez RI, Collins GK: Wernicke’s encephalopathy: a complication of chronic hemodialysis. Arch Neurol 18: 248–259, 1968.

    Article  PubMed  CAS  Google Scholar 

  100. Kimmel PL, Miller G, Mendelson WB: Sleep apnoea syndrome in chronic renal disease. Am J Med 86: 308–314, 1989.

    Article  PubMed  CAS  Google Scholar 

  101. Kimmel PL: Sleep disorders in hemodialysis patients. In: JP Bosch, JH Stein, eds, Contemporary Issues in Nephrology. Vol. 27: Hemodialysis: high-efficiency treatments. Churchill Livingstone, New York, pp 295–308, 1993.

    Google Scholar 

  102. Sullivan CE, Berthon-Jones M, Issa FG: Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet i: 862, 1981.

    Google Scholar 

  103. Benz RL, Pressman MR, Schliefer CR, Peterson DD: Sleep disorder profiles in chronic renal failure patients: successful intervention with nasal continuous positive airway pressure (abstract). Am J Kidney Dis 20: A1, 1992.

    Google Scholar 

  104. Mitler MM, Browman CP, Menn SJ, et al.: Nocturnal myoclonus: treatment efficacy of clonazepam and ternazepam. Sleep 9: 385, 1986.

    PubMed  CAS  Google Scholar 

  105. Olsen CA: A statistical review of variables predictive of adjustment in hemodialysis patients. Nephrol Nurse 5: 16–27, 1983.

    PubMed  CAS  Google Scholar 

  106. Levenson JL, Glocheski S: Psychological factors affecting end-stage renal disease. Psychosomatics 32: 382–389, 1991.

    Article  PubMed  CAS  Google Scholar 

  107. Kimmel PC, Weihs K, Peterson RA: Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 3: 12–27, 1993.

    Google Scholar 

  108. Locsey L, Balogh L, Toth E: Psychological effects of chronic haemodialysis. Int Urol Nephrol 19: 91–100, 1987.

    Article  PubMed  CAS  Google Scholar 

  109. Neu S, Kjellstrand CM: Stopping long-term dialysis: an empirical study of withdrawal of life-supporting treatment. N Engl J Med 314: 14–20, 1986.

    Article  PubMed  CAS  Google Scholar 

  110. Wolcott DL, Marsh JT, La Rue A, Can C, Nissenson AR: Recombinant human erythropoietin therapy may improve quality of life and cognitive function in chronic hemodialysis patients. Am J Kidney Dis 14:478-185,1989.

    Google Scholar 

  111. Friedman EA, Lundin AP III: Outcome and complication of chronic hemodialysis. In: RW Schrier, CW Gottschalk, eds, Diseases of the Kidney, 5th ed. Little, Brown, Boston, pp 3069–3095, 1993.

    Google Scholar 

  112. Kennedy SH, Craven JL, Rodin GM: Major depression in renal dialysis patients: an open trial of antidepressant therapy. J Clin Psychiatry 50: 60–63, 1989.

    PubMed  CAS  Google Scholar 

  113. Roose SP, Glassman AH, Dalack GW: Depression, heart disease, and tricyclic antidepressants. J Clin Psychiatry 50 (Suppl): 12–16, 1989.

    PubMed  Google Scholar 

  114. Pasquali S, Casanova S, Zucchelli A, Zucchelli P: Long-term survival patients with acute and severe renal failure due to multiple myeloma. Clin Nephrol 34: 247–254, 1990.

    PubMed  CAS  Google Scholar 

  115. Zucchelli P, Paquali S, Cagnoli L, Ferrari G: Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 33: 1175–1180, 1988.

    Article  PubMed  CAS  Google Scholar 

  116. Bardwick PA, Zvaifler NJ, Gill GN, Newman D, Greenway GD, Resnick DL: Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes: the POEMS syndrome, report on two cases and review of the literature. Medicine (Baltimore) 59: 311–321, 1980.

    CAS  Google Scholar 

  117. Fagerburg SE: Diabetic neuropathy: a clinical and histologic study on the significance of vascular affections. Acta Med Scand 164 (Suppl 345):l-80,1959.

    Google Scholar 

  118. Evans WE, Manninen DL, Garrison LP, et al.: The quality of life of patients with end-stage renal disease. N Engl J Med 312: 553–558, 1985.

    Article  PubMed  CAS  Google Scholar 

  119. Krane EJ, Roackhoff MA, Wallman JD, Wolfsldorf JI: Subclinical brain swelling in children during treatment of diabetic ketoacidosis. N Engl] Med 312: 1147–1151, 1985.

    Article  CAS  Google Scholar 

  120. Keller V, Berger W, Troug P: Course and prognosis of 86 episodes of diabetic coma: a five year experience with a uniform schedule of treatment. Diabetologia 11: 93–100, 1975.

    Article  PubMed  CAS  Google Scholar 

  121. Podolsky S: Hyperosmolar non-ketotic coma in the elderly diabetic. Med Clin North Am 62: 815–828, 1978.

    PubMed  CAS  Google Scholar 

  122. McCurdy DK: Hyperosmolar hyperglycaemic non-ketotic diabetic coma. Med Clin North Am 54: 683–699, 1970.

    PubMed  CAS  Google Scholar 

  123. Asbury AK: Focal and multifocal neuropathies of diabetes. In: PJ Dyck, PK Thomas, AK Asbury, et al, eds, Diabetic Neuropathy. WB Saunders, Philadelphia, pp 45–55, 1987.

    Google Scholar 

  124. Amair P, Khanna R, Leibel B, et al: Continuous ambulatory peritoneal dialysis in diabetics with end-stage renal disease. N Engl J Med 306: 625–630, 1982.

    Article  PubMed  CAS  Google Scholar 

  125. Tegner R: The effect of skin temperature on viibratory sensitivity in polyneuropathy. J Neurol Neurosurg Psychiatry 48: 176–178, 1985.

    Article  PubMed  CAS  Google Scholar 

  126. Najarian JS, Sutherland DER, Simmons RL, et al.: Ten year experience with renal transplantation in juvenile onset diabetes. Ann Surg 190: 487–500, 1979.

    Article  PubMed  CAS  Google Scholar 

  127. Solders G, Wilczek H, Gunnarsson R, et al.: Effects of combined pancreatic and renal transplantation on diabetic neuropathy; a two-year follow-up study. Lancet 2: 1232–1235, 1987.

    Article  PubMed  CAS  Google Scholar 

  128. Moore PM, Fauci AS: Neurologic manifestations of systemic vasculitis: a retrospective and prospective study of the clinico-pathologic features and responses to therapy in 25 patients. Am J Med 71: 517–524, 1981.

    Article  PubMed  CAS  Google Scholar 

  129. Sanford JP: Epidemiology and root of the problem. In: RK Root, MA Sande, eds, Septic Shock. Churchill Livingstone, New York, pp 1–11, 1985.

    Google Scholar 

  130. Rao TK, Friedman EA, Nicastri AD: The types of renal disease in acquired immune deficiency syndrome. N Engl J Med 316: 1062–1068, 1987.

    Article  PubMed  CAS  Google Scholar 

  131. Bredesen DE, Levy RM, Rosenblum ML: Human immunodeficiency virus-related neurological dysfunction. In: MJ Aminoff, ed, Neurology and General Medicine. The Neurological Aspects of Medical Disorders, Chapter 37. Churchill Livingstone, New York, pp 673–679, 1989.

    Google Scholar 

  132. Miller RG, Parry GJ, Pfaeffl W, Lang W, Lippert R, Kiprov D: The spectrum of peripheral neuropathy associated with ARC and AIDS. Muscle Nerve 11: 857–863, 1988.

    Article  PubMed  CAS  Google Scholar 

  133. Ayms JC, Krothapalli RK, Arieff AI: Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. N Engl J Med 317: 1190–1195, 1987.

    Article  Google Scholar 

  134. Tomson CRV, Venning MC, Ward MK: Blood pressure and erythropoietin (letter). Lancet ii: 351, 1988.

    Google Scholar 

  135. Sande MA, Mandell GL: Antimicrobial agents: the aminoglycosides. In: AG Gilman, LS Goodman, TW Rail, F Murad, eds, Goodman and Gilman’s The Pharmacological Basis of Therapeutics, 7th ed, vol 51. Macmillian, New York, pp 1150–1169, 1985.

    Google Scholar 

  136. Cuss FMC, Carmichael DJS, Allington A, Hulme B: Tubercolosis in renal failure: a high incidence in patients born in the third world. Clin Nephrol 25: 129–133, 1986.

    PubMed  CAS  Google Scholar 

  137. Kaplan JG, Barasch E, Hirschfeld A, Ross L, Einberg K, Gordon M: Spinal epidural lipomatosis: a serious complication of iatrogenic Cushing’s syndrome. Neurology 39: 1031–1034, 1989.

    Article  PubMed  CAS  Google Scholar 

  138. Kahan BD, Flechner SM, Lorber MI, et al.: Complication of cyclosporine therapy. World J Surg 10: 348–360, 1986.

    Article  PubMed  CAS  Google Scholar 

  139. Poison RJ, Powell-Jackson PR, Williams R: Convulsions associated with cyclosporin A in transplant recipients. Br Med J 290: 1003, 1985.

    Google Scholar 

  140. Hughes RL: Cyclosporin-related central nervous system toxicity in cardiac transplantation. N Engl J Med 323: 420–121, 1990.

    Article  PubMed  CAS  Google Scholar 

  141. Atkinson K, Biggs JC, Karveniza P, et al: Spinal cord cer-ebellar-like syndromes associated with the use of cyclosporine in human recipients of allogenic marrow transplants. Transplant Proc 17: 1673–1675, 1985.

    PubMed  CAS  Google Scholar 

  142. Martin MA, Massanari M, Nighiem DD, Smith JL, Corry RJ: Nosocomial aseptic meningitis associated with administration of OKT3. JAMA 259: 2002–2005, 1988.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology and Dialysis, G. D’Annunzio University Institute of Nephrology University of Chieti, S. Camillo De Lellis Hospital, S Camillo De Lellis Hospital, Chieti, 66100, Italy

    Alberto Albertazzi M.D. (Professor of Medicine and Nephrology, Chief)

  2. Institute of Nephrology, University of Chieti, S.Camillo De Lellis Hospital, Chieti, 66100, Italy

    Mario Bonomini M.D. & Paolo Cappelli M.D.

Authors
  1. Alberto Albertazzi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mario Bonomini M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paolo Cappelli M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Wadi N. Suki M.D. Shaul G. Massry M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media New York

About this chapter

Cite this chapter

Albertazzi, A., Bonomini, M., Cappelli, P. (1998). Neurological and Psychiatric Disorders in Renal Diseases. In: Suki, W.N., Massry, S.G. (eds) Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-6632-5_52

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-6632-5_52

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-6634-9

  • Online ISBN: 978-1-4757-6632-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation